| Serial Number | 88452967 |
| Word Mark | AZURITY PHARMACEUTICALS |
| Filing Date | Thursday, May 30, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 24, 2020 |
| Registration Number | 6206671 |
| Registration Date | Tuesday, November 24, 2020 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 3, 2020 |
| Goods and Services | pharmaceutical preparations sold as a kit for use by pharmacists and physicians in creating compounded hormone replacement medicines, topical anti-inflammatory and ultrasound gels, pain and gastrointestinal disorders treatment medicines, and anti-inflammatory, antimicrobial, and antifungal treatment medicines; medicines for the treatment of cardiovascular diseases and disorders, colitis, muscle spasm, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; antibiotics; pharmaceutical products for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders having vancomycin, enalapril, lisinopril, and methotrexate as the active pharmaceutical ingredient; antacids; muscle relaxants; hormone replacement medicines; topical anti-inflammatory and ultrasound gels; pharmaceutical preparation for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; pharmaceuticals for use in the treatment of cancer and autoimmune diseases and disorders, and for the treatment and prevention of renal, oncological, inflammatory, gastrointestinal, gastroesophageal, and cardio-vascular diseases and disorders |
| Description of Mark | The mark consists of a series of generally hexagonal shaded polygons forming a swirl with a shaded circle at the top of the swirl, with the shapes being colored dark orange, orange, yellow, green, turquoise, dark turquoise, light blue, blue, navy, and purple, all to the left of the purple stylized wording "AZURITY" above the turquoise stylized wording "PHARMACEUTICALS". |
| NOT AVAILABLE | "PHARMACEUTICALS" |
| Indication of Colors claimed | The color(s) dark orange, orange, yellow, green, turquoise, dark turquoise, light blue, blue, navy, and purple is/are claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 14, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, August 31, 2020 |
| First Use In Commerce Date | Monday, August 31, 2020 |
| Party Name | AZURITY PHARMACEUTICALS, INC. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | WOBURN, MA 01801 |
| Party Name | AZURITY PHARMACEUTICALS, INC. |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 03 - Corporation |
| Address | WOBURN, MA 01801 |
| Party Name | CutisPharma, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Woburn, MA 01801 |
| Party Name | CutisPharma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Woburn, MA 01801 |
| Event Date | Event Description |
| Monday, June 3, 2019 | NEW APPLICATION ENTERED |
| Friday, June 14, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, June 15, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, August 8, 2019 | ASSIGNED TO EXAMINER |
| Friday, August 9, 2019 | NON-FINAL ACTION WRITTEN |
| Friday, August 9, 2019 | NON-FINAL ACTION E-MAILED |
| Friday, August 9, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 29, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 29, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 29, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 30, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 12, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 3, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 3, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 28, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, April 29, 2020 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, October 6, 2020 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, October 20, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, October 6, 2020 | USE AMENDMENT FILED |
| Wednesday, October 21, 2020 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, October 21, 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Thursday, October 22, 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, November 24, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, March 19, 2025 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Monday, November 24, 2025 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |